CytoSorbents
CTSO0.36093.08% ( +0.0108 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: CytoSorbents(CTSO) predict that the Revenue is 8.864 M (+1.57%), Miss estimate;the EBIT is -3.044 M (+21.69%), Beat estimate;the EPS is -0.08 (-300%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.01B1.57%
0.01B7.29%
-0.00B5.72%
EBITExceed expectations
-0.00B21.69%
-0.00B20.96%
+0.00B0.73%
EPSMiss expectations
-0.08300.00%
-0.055175.00%
-0.0250125.00%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue9.346 M
Estimate EBIT-2.396 M
Estimate EPS-0.0433
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf